| 1 |
30023695 | A Simple Isomerization of the Purine Scaffold of a Kinase Inhibitor, Roscovitine, Affords a Four- to Seven-Fold Enhancement of Its Affinity for Four CDKs. Could This Be Traced Back to Conjugation-Induced Stiffenings/Loosenings of Rotational Barriers? | 2017 Jul 31 |
2 |
| 2 |
26207228 | Roscovitine in cancer and other diseases. | 2015 Jun |
1 |
| 3 |
21641213 | Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: synthesis, neuronal cell culture investigations, and CDK5 docking studies. | 2011 Jul 1 |
1 |
| 4 |
16407256 | Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics. | 2006 Mar 17 |
1 |
| 5 |
14990704 | Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus. | 2004 Mar |
1 |
| 6 |
15308730 | Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors. | 2004 Sep |
1 |
| 7 |
10465404 | Synthesis and in vitro evaluation of novel 2,6,9-trisubstituted purines acting as cyclin-dependent kinase inhibitors. | 1999 Jul |
1 |